Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
Clover Health Investments, Corp. (NASDAQ: CLOV) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $6.00 price target on the stock.
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now [Yahoo! Finance]
Clover Health Investments Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call Highlights: Strong Financial ... [Yahoo! Finance]